Clicky

Aegirbio AB(AEGIR)

Description: AegirBio AB (publ), a diagnostic company, develops and commercializes tests for monitoring and optimizing the dosage of biological drugs Sweden and Asia. The company focuses on the neurology, cancer, and autoimmune diseases therapeutic areas. It offers moNATor, a first dose-monitoring laboratory test to test multiple sclerosis for healthcare professionals and patients; and Viraspec, a COVID-19 saliva test kit. AegirBio AB (publ) was incorporated in 2019 and is headquartered in Lund, Sweden.


Keywords: Medicine Cancer Clinical Medicine Autoimmune Disease Multiple Sclerosis Neurology Toxicology Mo Na Tor Saliva Testing

Home Page: aegirbio.com

Scheelevägen 27
Lund, 223 63
Sweden
Phone: 46 4 62 86 54 00


Officers

Name Title
Dr. Bradley Messmer Ph.D. CEO, Chief Scientific Officer & Member of the Board
Patrik Gotthardt Interim Chief Financial Officer
Mr. Jens Patrik Elfwing COO & Director

Exchange: ST

Country: SE : Sweden

Currency: Swedish krone (kr)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 0.2946
Price-to-Sales TTM: 31.8028
IPO Date:
Fiscal Year End: December
Full Time Employees: 17
Back to stocks